Evidence map›Paper›PMID 23429513›Full record

ArticleSensors (Basel, Switzerland)2013

High throughput molecular confirmation of β-thalassemia mutations using novel TaqMan probes.

Siew Leng Kho, Kek Heng Chua, Elizabeth George, Jin Ai Mary Anne Tan

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Siew Leng KhoDepartment of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia. khosiewleng@yahoo.com
Kek Heng Chua
Elizabeth George
Jin Ai Mary Anne Tan
University of Malaya · MYUniversiti Putra Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-Thalassemia is a public health problem where 4.5% of Malaysians are β-thalassemia carriers. The genetic disorder is caused by defects in the β-globin gene complex which lead to reduced or complete absence of β-globin chain synthesis. Five TaqMan genotyping assays were designed and developed to detect the common β-thalassemia mutations in Malaysian Malays. The assays were evaluated with 219 "blinded" DNA samples and the results showed 100% sensitivity and specificity. The in-house designed TaqMan genotyping assays were found to be cost- and time-effective for characterization of β-thalassemia mutations in the Malaysian population.

Indexed as

AllelesBase Sequencebeta-ThalassemiaDNADNA Mutational AnalysisDNA ProbesGenotyping TechniquesHigh-Throughput Screening AssaysHumansMutationReproducibility of ResultsTaq PolymeraseTemplates, GeneticDNADNA ProbesTaq Polymerase

Identifiers

PMID23429513
PMCPMC3649372
OpenAlexW2088812525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.